Literature DB >> 12756028

Bull's eye maculopathy with deferoxamine.

V Bansal1, I Elgarbly, F D Ghanchi, P L Atkinson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12756028     DOI： 10.1034/j.1600-0609.2003.00073.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN： 0902-4441            Impact factor:   2.997


× No keyword cloud information.
  8 in total

1.  Macular vitelliform lesion in desferrioxamine-related retinopathy.

Authors:  Mohamed A Genead; Gerald A Fishman; Anastasios Anastasakis; Martin Lindeman
Journal:  Doc Ophthalmol       Date:  2010-06-09       Impact factor: 2.379

2.  Rapid development of severe toxic retinopathy associated with continuous intravenous deferoxamine infusion.

Authors:  T Y Y Lai; G K Y Lee; W-M Chan; D S C Lam
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

3.  Electrophysiological assessment for early detection of retinal dysfunction in β-thalassemia major patients.

Authors:  Maria Dettoraki; Antonis Kattamis; Ioannis Ladas; Konstantinos Maragkos; Chryssanthi Koutsandrea; Klio Chatzistefanou; Konstantinos Laios; Dimitrios Brouzas; Marilita M Moschos
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-03-30       Impact factor: 3.117

4.  Multimodal imaging in a case of deferoxamine-induced maculopathy.

Authors:  Rony Gelman; Szilard Kiss; Stephen H Tsang
Journal:  Retin Cases Brief Rep       Date:  2014

Review 5.  Functional and Structural Abnormalities in Deferoxamine Retinopathy: A Review of the Literature.

Authors:  Maura Di Nicola; Giulio Barteselli; Laura Dell'Arti; Roberto Ratiglia; Francesco Viola
Journal:  Biomed Res Int       Date:  2015-06-08       Impact factor: 3.411

Review 6.  β-Thalassemia and ocular implications: a systematic review.

Authors:  Aliki Liaska; Petros Petrou; Constantinos D Georgakopoulos; Ramza Diamanti; Dimitris Papaconstantinou; Menelaos G Kanakis; Ilias Georgalas
Journal:  BMC Ophthalmol       Date:  2016-07-08       Impact factor: 2.209

Review 7.  Clinical applications of fundus autofluorescence in retinal disease.

Authors:  Madeline Yung; Michael A Klufas; David Sarraf
Journal:  Int J Retina Vitreous       Date:  2016-04-08

8.  Long-Term Effects of Iron Chelating Agents on Ocular Function in Patients with Thalassemia Major.

Authors:  Raffaele Nuzzi; Giada Geronazzo; Federico Tridico; Alessia Nuzzi; Paolo Caselgrandi; Antonio Giulio Piga
Journal:  Clin Ophthalmol       Date:  2021-05-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.